Li Kang Biomedical Co., Ltd. (TPEX:6242)
Taiwan · Delayed Price · Currency is TWD 38.00
+0.10 (0.26%)
Apr 20, 2026, 1:24 PM CST
Li Kang Biomedical Revenue
In the year 2025, Li Kang Biomedical had annual revenue of 589.21M TWD with 4.19% growth. Li Kang Biomedical had revenue of 171.58M in the quarter ending December 31, 2025, with 4.69% growth.
Revenue
589.21M
Revenue Growth
+4.19%
P/S Ratio
2.05
Revenue / Employee
4.83M
Employees
122
Market Cap
1.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 589.21M | 23.69M | 4.19% |
| Dec 31, 2024 | 565.52M | -63.86M | -10.15% |
| Dec 31, 2023 | 629.38M | -54.87M | -8.02% |
| Dec 31, 2022 | 684.25M | 297.28M | 76.82% |
| Dec 31, 2021 | 386.97M | -69.75M | -15.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hotai Motor | 281.97B |
| Far Eastern New Century | 254.06B |
| Taiwan Mobile | 198.76B |
| King Slide Works | 17.50B |
| Singtex Industrial | 3.61B |
| Redwood Group | 2.71B |
| Scan-D | 2.21B |
| Bausen | 2.14B |